Open Source Biology & Genetics Interest Group

Open source scripts, reports, and preprints for in vitro biology, genetics, bioinformatics, crispr, and other biotech applications.

Mitochondrial DNA Copy Number in Rett Syndrome Caused by MECP2 Variants


Available online 4 October 2021

The Journal of Pediatrics rights and content



To determine changes of mitochondrial DNA (mtDNA) copy number in peripheral blood in Rett syndrome caused by methyl-CpG-binding protein-2 (MECP2) variants and explore the mechanism of mitochondrial dysfunction in RTT.

Study design

Female patients who were diagnosed as RTT and had MECP2 variants (n = 142) were recruited in this study, compared with the same number of age- and sex-matched healthy control group. MtDNA copy number was quantified by real-time quantitative polymerase chain reaction with TaqMan probes. The differences in mtDNA copy number between the RTT group and the control group were analyzed by the independent sample t-test. Linear regression, biserial correlation analysis, and one-way analysis of variance were applied for the correlations between age, clinical severity, variant types, functional domains, hot-spot variants and mtDNA copy number.


MtDNA copy number was found to increase significantly in RTT patients with MECP2 gene variants than in control subjects in this study. Age, clinical severity, variant types, functional domains, and hot-spot variants were not related to mtDNA copy number in RTT patients.


The mtDNA copy number of RTT patients has increased significantly, suggesting that changes in mitochondrial function in RTT patients trigger a compensatory increase in mtDNA copy number, and providing new possibilities for RTT treatments such as mitochondria-targeted therapies.



Methyl-CpG-binding protein-2


Real‐time quantitative polymerase chain reaction


NADH dehydrogenase subunit


Hemoglobin subunit beta


One-way analysis of variance


Methyl‐CpG‐binding domain


Transcription repression domain


Nuclear localization signal

View full text

© 2021 Published by Elsevier Inc.

Read more here: Source link

Join us at CRISPR workshops in Koper, Slovenia in 2023. Erasmus+ funds available!
This is default text for notification bar